Corporate Profile
Akero Therapeutics is a clinical stage biopharmaceutical company focused on delivering transformational medicines to patients with high unmet medical need. Our current focus is on advancing our lead program efruxifermin (EFX) to provide a powerful new treatment for patients with NASH, a disease for which there are currently no marketed therapies.
Corporate Presentation
Share Price
Akero Therapeutics
Sep 7, 2024 11:20 PM EDT
Data Provided by Refinitiv. Minimum 15 minutes delayed.
Data Provided by Refinitiv. Minimum 15 minutes delayed.